Filing Flows

Filing Flows › AtriCure (ATRC) › Guidance history

AtriCure (ATRC) guidance history: what it guided and what it reported

AtriCure gave guidance in 3 earnings releases on file since May 6, 2026. Its releases raised guidance once and lowered it 0 times.

Revenue

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$600M–$610M (May 6, 2026) → reaffirmed $602M–$610M (Jul 23, 2026) → raised $606M–$610M (Nov 3, 2026)—to be reported—

Adjusted EBITDA

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$80.0M–$82.0M (May 6, 2026) → raised $85.0M–$89.0M (Jul 23, 2026) → raised $91.0M–$94.0M (Nov 3, 2026)—to be reported—

Adjusted EPS

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$0.09–$0.15 (May 6, 2026) → raised $0.24–$0.32 (Jul 23, 2026) → raised $0.40–$0.46 (Nov 3, 2026)—to be reported—

The latest quarter

AtriCure, Q3 2026: revenue $154M (+15% year over year), operating margin 2.8%, net earnings $4.1M, operating cash flow $30.3M. The chart follows the revenue to costs, profit and cash.

Questions

Does AtriCure beat its guidance?

AtriCure gave guidance in 3 earnings releases on file since May 6, 2026. Its releases raised guidance once and lowered it 0 times.

How often does AtriCure raise guidance?

Its earnings releases raised guidance once and lowered it 0 times since May 6, 2026.

Latest guidance and outlook →

Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.